41. PATH-62. QUANTITATIVE ANALYSIS OF SEX-ASSOCIATED MGMT METHYLATION IN NEWLY DIAGNOSED GLIOBLASTOMA. (11th November 2019) Authors: Barnett, Addison; Saeed Bamashmos, Anas; Li, Hong; Bosler, David; Lathia, Justin; Yeaney, Gabrielle; Ali, Assad; Sagar, Soumya; Mohammadi, Alireza; Stevens, Glen; Angelov, Lilyana; Peereboom, David; Barnett, Gene; Ahluwalia, Manmeet Journal: Neuro-oncology Issue: Volume 21(2019)Supplement 6 Page Start: vi157 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
42. RADI-35. AN ANALYSIS OF RESPONSE ENDPOINTS FOR BRAIN METASTASIS PATIENTS TREATED WITH STEREOTACTIC RADIOSURGERY AND PD(L)-1 INHIBITORS. (12th August 2019) Authors: Kotecha, Rupesh; Miller, Jacob; Kim, Joseph; Juloori, Aditya; Chao, Samuel; Murphy, Erin; Peereboom, David; Mohammadi, Alireza; Barnett, Gene; Vogelbaum, Michael; Angelov, Lilyana; Suh, John; Ahluwalia, Manmeet Journal: Neuro-oncology advances Issue: Volume 1(2019)Supplement 1 Page Start: i28 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
43. RBTT-01. RANDOMIZED PHASE 2 OPEN LABEL STUDY OF NIVOLUMAB PLUS STANDARD DOSE BEVACIZUMAB VERSUS NIVOLUMAB PLUS LOW DOSE BEVACIZUMAB IN RECURRENT GLIOBLASTOMA. (5th November 2018) Authors: Ahluwalia, Manmeet; Peereboom, David; Schilero, Cathy; Forst, Deborah; Wong, Eric; Wen, Patrick; Reardon, David Journal: Neuro-oncology Issue: Volume 20(2018)Supplement 6 Page Start: vi234 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
44. RBTT-08. A RANDOMIZED PHASE 2 OPEN LABEL STUDY OF NIVOLUMAB PLUS STANDARD DOSE BEVACIZUMAB VERSUS NIVOLUMAB PLUS LOW DOSE BEVACIZUMAB IN RECURRENT GLIOBLASTOMA (GBM). (11th November 2019) Authors: Ahluwalia, Manmeet; Fallah, Jaleh; Peereboom, David; Schilero, Cathy; Ali, Assad; Forst, Deborah; Wong, Eric; Wen, Patrick; Reardon, David Journal: Neuro-oncology Issue: Volume 21(2019)Supplement 6 Page Start: vi220 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
45. RTHP-20. MULTI-INSTITUTIONAL ANALYSIS OF HIGH-RISK WHO GRADE II OLIGODENDROGLIOMA TREATED WITH ADJUVANT RADIOTHERAPY PLUS TEMOZOLOMIDE (TMZ) VERSUS PROCARBAZINE, LOMUSTINE, AND VINCRISTINE (PCV). (11th November 2019) Authors: Tom, Martin; Routman, David; Laack, Nadia; Frechette, Kelsey; Park, Deborah; (Auston) Wei, Wei; Leyrer, Marc; Peereboom, David; Ahluwalia, Manmeet; Chao, Samuel; Suh, John; Murphy, Erin Journal: Neuro-oncology Issue: Volume 21(2019)Supplement 6 Page Start: vi213 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
46. THER-02. IMPACT OF SYSTEMIC THERAPY IN MELANOMA BRAIN METASTASIS. (12th August 2019) Authors: Sagar, Soumya; Lauko, Adam; Barnett, Addison; Wei, Wei; Chao, Samuel; Peereboom, David; Stevens, Glen; Angelov, Lilyana; Yu, Jennifer; Murphy, Erin; Mohammadi, Alireza; Suh, John; Barnett, Gene; Ahluwalia, Manmeet Journal: Neuro-oncology advances Issue: Volume 1(2019)Supplement 1 Page Start: i11 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
47. THER-09. IMPACT OF KRAS MUTATION STATUS ON THE EFFICACY OF IMMUNOTHERAPY IN LUNG CANCER BRAIN METASTASES. (12th August 2019) Authors: Lauko, Adam; Ali, Assad; Sagar, Soumya; Barnett, Addison; Li, Hong; Chao, Samuel; Pennell, Nathan; Stevens, Glen; Peereboom, David; Yu, Jennifer; Murphy, Erin; Angelov, Lilyana; Mohammadi, Alireza; Suh, John; Barnett, Gene; Ahluwalia, Manmeet Journal: Neuro-oncology advances Issue: Volume 1(2019)Supplement 1 Page Start: i12 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
48. THER-10. IMPACT OF BRAF MUTATIONAL STATUS ON THE EFFICACY OF IMMUNOTHERAPY FOR MELANOMA BRAIN METASTASES. (12th August 2019) Authors: Lauko, Adam; Sagar, Soumya; Barnett, Addison; Wei, Wei; Chao, Samuel; Stevens, Glen; Peereboom, David; Yu, Jennifer; Murphy, Erin; Angelov, Lilyana; Mohammadi, Alireza; Suh, John; Barnett, Gene; Ahluwalia, Manmeet Journal: Neuro-oncology advances Issue: Volume 1(2019)Supplement 1 Page Start: i12 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
49. THER-13. IMMUNOTHERAPY VERSUS STANDARD OF CARE IN MELANOMA BRAIN METASTASES WITH KNOWN BRAF STATUS. (12th August 2019) Authors: Barnett, Addison; Sagar, Soumya; Lauko, Adam; Wei, Wei; Chao, Samuel; Peereboom, David; Stevens, Glen; Angelov, Lilyana; Yu, Jennifer; Murphy, Erin; Mohammadi, Alireza; Suh, John; Barnett, Gene; Ahluwalia, Manmeet Journal: Neuro-oncology advances Issue: Volume 1(2019)Supplement 1 Page Start: i13 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
50. THER-14. INFLUENCE OF CLINICAL PARAMETERS ON THE EFFICACY OF IMMUNE CHECKPOINT INHIBITORS IN PATIENTS WITH NON-SMALL CELL LUNG CANCER BRAIN METASTASES (NSCLCBM). (12th August 2019) Authors: Lauko, Adam; Thapa, Bicky; Muhsen, Baha'eddin; Borghei-Razavi, Hamid; Wei, Wei; Chao, Samuel; Stevens, Glen; Peereboom, David; Yu, Jennifer; Murphy, Erin; Angelov, Lilyana; Mohammadi, Alireza; Suh, John; Barnett, Gene; Pennell, Nathan; Ahluwalia, Manmeet Journal: Neuro-oncology advances Issue: Volume 1(2019)Supplement 1 Page Start: i13 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗